首页> 外文期刊>Journal of Enam Medical College >Drug Management Pattern and Their Adverse Effects in Patients of Cervical Carcinoma Attending Two Tertiary Care Hospitals in Dhaka City
【24h】

Drug Management Pattern and Their Adverse Effects in Patients of Cervical Carcinoma Attending Two Tertiary Care Hospitals in Dhaka City

机译:达卡市两家三级医院子宫颈癌患者的药物管理模式及其不良反应

获取原文
       

摘要

Background: Cervical cancer remains a significant health burden worldwide. It is the second most commonly diagnosed cancer and third leading cause of cancer death among females in least developed countries. There were an estimated 527,600 new cervical cancer cases and 265,700 deaths worldwide in 2012. Bangladesh stands 11th in the world in cervical cancer fatalities with 17.9 women dying in 100,000 due to the largely sexually transmitted disease every year.Objective: The present study was done to evaluate the pattern of drug management, their adverse effects and socio-demographic characteristics of the patients of cervical carcinoma admitted and treated with chemotherapy in two tertiary care hospitals of Bangladesh.Materials and Methods: It was a cross-sectional observational study carried out from January to December 2015 at Dhaka Medical College Hospital and National Institute of Cancer Research Hospital. During this period, 109 patients were selected by purposive sampling technique using a set of pre-tested structured questionnaire. Data analysis was done using SPSS version 21.0.Results: Most of the patients were in 5th decade (51.4%), from low (59.6%) income family and were married (98.16%). The mean duration of treatment for cancer was found 11.34 ± 5.32 months. Cisplatin (93.57%), 5 fluorouracil (63.3%) and paclitaxel (12.8%) were the most frequently prescribed drugs either alone or in combination. The adverse effects for cisplatin were gastrointestinal toxicity, nephrotoxicity, myelosuppresion and for 5-fluorouracil were myelosuppression, diarrhea, hyperpigmentation, dizziness, neuropathy, increased risk of infection.Conclusion: The combination of cisplatin and 5-fluorouracil was mostly (50.45%) prescribed followed by cisplatin alone (26.6%) to treat the patients of cervical carcinoma in Bangladesh.
机译:背景:宫颈癌仍然是全球范围内的重大健康负担。它是最不发达国家女性中第二大最常被诊断出的癌症和第三大癌症死因。 2012年,全球估计有527,600例新子宫颈癌病例和265,700例死亡。孟加拉国在宫颈癌死亡人数中排名世界第11位,每年因主要性传播疾病而死亡的17.9名妇女中有100,000人死亡。评估孟加拉国两家三级医院的药物治疗模式,其不良反应和接受化学疗法治疗的宫颈癌患者的社会人口统计学特征。材料与方法:这是一项从一月开始进行的横断面观察研究到2015年12月在达卡医学院附属医院和美国国立癌症研究所的医院就诊。在此期间,使用一组预先测试的结构化问卷,通过有针对性的抽样技术选择了109例患者。使用SPSS 21.0版进行数据分析。结果:大多数患者在5岁以下(51.4%),来自低收入家庭(59.6%),并且已婚(98.16%)。癌症的平均治疗时间为11.34±5.32个月。顺铂(93.57%),5氟尿嘧啶(63.3%)和紫杉醇(12.8%)是单独或联合使用的最常用处方药。对顺铂的不良反应是胃肠道毒性,肾毒性,骨髓抑制,对5-氟尿嘧啶的不良反应是骨髓抑制,腹泻,色素沉着,头晕,神经病变,感染风险增加。结论:处方中顺铂和5-氟尿嘧啶的联合使用率最高(50.45%)其次是单独使用顺铂(26.6%)治疗孟加拉国的宫颈癌患者。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号